Scienture Holdings, Inc. - SIC # 5270 -

Ticker Exchange SIC # Website Latest Ticker
SCNX Nasdaq 5270 scienture.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Scienture Holdings, Inc.

Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025 - Dec 17th, 2024 1:05 pm
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041 - Dec 10th, 2024 1:05 pm
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement - Nov 26th, 2024 9:05 pm
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - Sep 24th, 2024 12:01 pm